Louis Kayitalire

Insider Reports History

Location
Cambridge, United Kingdom
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Louis Kayitalire:

Company Role Class Num Shares Value Price $ Report Date Ownership
F-star Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 0 $7.12 08 Mar 2023 Direct
F-star Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to buy) 0 08 Mar 2023 Direct

Insider Reports Filed by Louis Kayitalire

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323007670-kayitalire-louis-2023-03-08 F-star Therapeutics, Inc. 08 Mar 2023 6 -$386,296 4 CHIEF MEDICAL OFFICER 09 Mar 2023, 08:21
/report/000120919122022302-kayitalire-louis-2022-03-31 F-star Therapeutics, Inc. 31 Mar 2022 1 $0 4 Chief Medical Officer 04 Apr 2022, 16:03
/report/000120919122002921-kayitalire-louis-2022-01-09 F-star Therapeutics, Inc. 09 Jan 2022 1 $0 4 Chief Medical Officer 11 Jan 2022, 16:32
/report/000120919121063046-kayitalire-louis-2021-11-02 F-star Therapeutics, Inc. 02 Nov 2021 2 -$437 4 Chief Medical Officer 04 Nov 2021, 21:34
/report/000120919121059842-kayitalire-louis-2021-10-04 F-star Therapeutics, Inc. 04 Oct 2021 1 -$462 4 Chief Medical Officer 06 Oct 2021, 16:38
/report/000120919121045957-kayitalire-louis-2021-07-02 F-star Therapeutics, Inc. 02 Jul 2021 1 -$8,885 4 Chief Medical Officer 07 Jul 2021, 21:13
/report/000120919121053224-kayitalire-louis-2020-11-20-restatement F-star Therapeutics, Inc. 20 Nov 2020 1 $0 4/A Chief Medical Officer 24 Aug 2021, 18:25